Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033 (SLVO) Price & Performance

Heron Therapeutics IncTrade
Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033Trade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033 — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033 trades at $69.5. The key difference: Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033 is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

HRTXSLVO
Market Cap
$61.47M
Sector
HealthIncome / Options Overlay
52-Week High
$1.49$107.41
52-Week Low
$0.32$61.81
Enterprise Value
$168.21M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX

About Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033

SLVO is an exchange-traded note issued by UBS AG that provides investors with exposure to the performance of a silver-based covered call strategy. The ETN tracks the daily return of the ISE Enhanced 100x Leveraged Silver ETN Index, which combines a long position in silver with a covered call strategy on the silver position. This strategy aims to generate current income from the option premiums, which can provide a buffer during sideways or slightly down markets for silver, but it also caps the potential gains from a significant rise in silver prices. As an ETN, it is subject to the credit risk of the issuer, UBS AG, and has an expiration date of April 21, 2033.

Read more on SLVO